Publications

Advisory Committee on Complementary Medicines meeting statement for 6 November 2025

This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations).

This web publication constitutes a notice for the purposes of regulation 42ZCZS and regulation of the 42ZCX Therapeutic Goods Regulations 1990 (the Regulations).

Interim decisions and invitation for comment. Closing date: 12 January 2026.

Interim decisions and invitation for comment. Closing date: 23 January 2026.

We conduct an annual stakeholder survey to improve the way we work with our stakeholders and help report on our key performance indicators.

The report includes data and feedback from the general public (consumers), people and organisations with a TGA business services account (opt-in stakeholders), and state and territory government representatives.

Advisory Committee on Complementary Medicines meeting statement for 31 July 2025

This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations).

Find out about the AIVC Recommendations for the Composition of Influenza Vaccines for Australia in 2026.

Publication of the decisions made by a delegate of the Secretary

Advisory Committee on Complementary Medicines meeting statement for 6 March 2025

This study by the TGA assesses the particle filtration efficiency of respirators listed in the ARTG or submitted for compliance testing during the COVID-19 pandemic.

The 86th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 14 August 2025.

Face masks that are intended by their manufacturer to prevent the transmission of diseases between people or are intended to be used in a healthcare environment, are medical devices

Advisory Committee on Vaccines meeting statement 53

Read our business plan 2025-26 to find out about our strategic priorities and activities.

Documents released under the FOI Act in the 2024/25 financial year

The 85th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 12 June 2025.

This Cost Recovery Implementation Statement (CRIS) 2025-2026 provides information on how we implement, and cost recover our regulatory activities.

Read the meeting statement from the meeting of the Advisory Committee on Medical Devices (ACMD).

Read the meeting statement from 13 February 2025 meeting of the Advisory Committee on Medical Devices (ACMD).

Detailed statistical information on Therapeutic Goods Administration performance in pre- and post-market activities.

This report provides information about our regulatory performance for the 2023-24 financial year.

This report provides an overview of pharmacovigilance inspection deficiencies in 2022, including a comparison to results from previous reporting periods.

Read the meeting statement from 12 December 2024 meeting of the Advisory Committee on Medical Devices (ACMD).